You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis
David C. Mohr; Donald E. Goodkin; Janeen Islar; Stephen L. Hauser; Claude P. Genain
Arch Neurol 2001; 58: 1081-1086.
[Abstract][Full text][PDF]
Original Contributions Factors Associated With Incident Human Immunodeficiency Virus–Dementia
Yaakov Stern; Michael P. McDermott; Steven Albert; Donna Palumbo; Ola A. Selnes; Justin McArthur; Ned Sacktor; Giovanni Schifitto; Karl Kieburtz; Leon Epstein; Karen S. Marder; for the Dana Consortium on the Therapy of HIV–Dementia and Related Cognitive Disorders
Arch Neurol 2001; 58: 473-479.
[Abstract][Full text][PDF]
Original Contributions Altered Mental Status in Patients With Cancer
Original Contributions Course of Depression During the Initiation of Interferon Beta-1a Treatment for Multiple Sclerosis
David C. Mohr; William Likosky; Pat Dwyer; Judy Van Der Wende; Arne C. Boudewyn; Donald E. Goodkin
Arch Neurol 1999; 56: 1263-1265.
[Abstract][Full text][PDF]
Special Articles Clinical Research Designs for Emerging Treatments for Alzheimer Disease: Moving Beyond Placebo-Controlled Trials
Original Contributions Quality of Life Perception in Patients With Intractable Epilepsy or Pseudoseizures
Joshua I. Breier; Kathleen L. Fuchs; Bonnie L. Brookshire; James Wheless; Azreena B. Thomas; Jules Constantinou; L. James Willmore
Arch Neurol 1998; 55: 660-665.
[Abstract][Full text][PDF]
Original Contributions Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation
Klaus Fassbender; Roland Schmidt; Reinald Mößner; Udo Kischka; Josy Kühnen; Andreas Schwartz; Michael Hennerici
Arch Neurol 1998; 55: 66-72.
[Abstract][Full text][PDF]
